DDAH2 and neoplasm: Kostorou et al. reported the involvement of dimethylarginine dimethylaminohydrolase (DDAH) in cerebral tumor growth and the development of tumor vasculature [69]; this enzyme metabolizes the endogenous NOS inhibitor, asymmetric dimethylarginine (ADMA).